2.50
Hdl Handle:
http://hdl.handle.net/10541/84098
Title:
Cholangiocarcinoma and the role of radiation and chemotherapy.
Authors:
Price, Patricia M
Abstract:
Cholangiocarcinoma is a rare tumor. Many cases are localized while metastatic disease within the liver and abdomen do occur. There is as yet no standard therapy for advanced bile duct tumors. Radiotherapy and chemotherapy are not curative modalities in this condition but are being assessed adjuvantly following surgery, and as palliative treatment in an attempt to either extend progression-free and overall survival or to palliate symptoms. Advances may be made by: (i) The combined use of radiation and chemotherapy, (ii) High dose conformal radiotherapy, (iii) Novel chemotherapeutic agents. Patients should be given the opportunity to participate in clinical trials.
Affiliation:
Department of Cancer Therapeutics, ICSM Academic, Department of Radiation Oncology, Christie Hospital, Manchester, England.
Citation:
Cholangiocarcinoma and the role of radiation and chemotherapy., 48 (37):51-2 Hepatogastroenterology
Journal:
Hepato-gastroenterology
Issue Date:
2001
URI:
http://hdl.handle.net/10541/84098
PubMed ID:
11268997
Type:
Article
Language:
en
ISSN:
0172-6390
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorPrice, Patricia Men
dc.date.accessioned2009-10-12T16:48:01Z-
dc.date.available2009-10-12T16:48:01Z-
dc.date.issued2001-
dc.identifier.citationCholangiocarcinoma and the role of radiation and chemotherapy., 48 (37):51-2 Hepatogastroenterologyen
dc.identifier.issn0172-6390-
dc.identifier.pmid11268997-
dc.identifier.urihttp://hdl.handle.net/10541/84098-
dc.description.abstractCholangiocarcinoma is a rare tumor. Many cases are localized while metastatic disease within the liver and abdomen do occur. There is as yet no standard therapy for advanced bile duct tumors. Radiotherapy and chemotherapy are not curative modalities in this condition but are being assessed adjuvantly following surgery, and as palliative treatment in an attempt to either extend progression-free and overall survival or to palliate symptoms. Advances may be made by: (i) The combined use of radiation and chemotherapy, (ii) High dose conformal radiotherapy, (iii) Novel chemotherapeutic agents. Patients should be given the opportunity to participate in clinical trials.en
dc.language.isoenen
dc.subjectBile Duct Canceren
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols-
dc.subject.meshBile Duct Neoplasms-
dc.subject.meshBile Ducts, Intrahepatic-
dc.subject.meshCholangiocarcinoma-
dc.subject.meshCombined Modality Therapy-
dc.subject.meshDose Fractionation-
dc.subject.meshHumans-
dc.subject.meshPalliative Care-
dc.subject.meshRadiotherapy-
dc.subject.meshRadiotherapy Dosage-
dc.titleCholangiocarcinoma and the role of radiation and chemotherapy.en
dc.typeArticleen
dc.contributor.departmentDepartment of Cancer Therapeutics, ICSM Academic, Department of Radiation Oncology, Christie Hospital, Manchester, England.en
dc.identifier.journalHepato-gastroenterologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.